Skip to main content
Screener/Healthcare/Drug Manufacturers - Specialty & Generic

EOLS — Evolus, Inc.

NASDAQ
$5.75-0.24 (-4.08%)
Small CapUnder $10Healthcare
$3.86
$9.35
$5.72
$6.01
EPS (TTM)$-0.67
P/E Ratio-6.58
Dividend Yield—
Market Cap$393.8M
Volume351K
Prev Close$6.01
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$73.1M-$10.7M$-0.1664.8%-14.6%
Q4 '25$90.3M$130K$0.0064.1%0.1%
Q3 '25$69.0M-$15.7M$-0.2466.5%-22.8%
Q2 '25$69.4M-$17.1M$-0.2765.3%-24.7%
Q1 '25$68.5M-$18.9M$-0.3068.1%-27.6%
Q4 '24$78.9M-$6.8M$-0.1163.8%-8.6%
Q3 '24$61.1M-$19.2M$-0.3070.2%-31.4%
Q2 '24$66.9M-$11.3M$-0.1870.3%-17.0%
Get Your Daily Market Recap